US Patent 8349851 JAK kinase modulating compounds and methods of use thereof

Patent 8349851 was granted and assigned to Ambit Biosciences on January, 2013 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Current Assignee

Ambit Biosciences

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

83498510

Patent Inventor Names

Sunny Abraham0

Mark W. Holladay0

Michael J. Hadd0

Qi Chao0

Eduardo Setti0

Gang Liu0

Date of Patent

January 8, 2013

Patent Application Number

127143230

Date Filed

February 26, 2010

Patent Primary Examiner

‌

Brian McDowell

Patent abstract

Provided herein are quinazoline compounds of formula (I):

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 8349851 JAK kinase modulating compounds and methods of use thereof

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API